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Abstract: Drug-induced liver injury (DILI) is the most common reason for failures during the drug
development process and for safety-related withdrawal of drugs from the pharmaceutical market.
Therefore, having tools and techniques that can detect hepatotoxic properties in drug candidates
at an early discovery stage is highly desirable. In this study, cell imaging counting was used to
measure in a fast, straightforward, and unbiased way the effect of paracetamol and tetracycline,
(compounds known to cause hepatotoxicity in humans) on the amount of DsRed-labeled hepatocytes
recovered by protease digestion from Tg(fabp10a:DsRed) transgenic zebrafish. The outcome was
in general comparable with the results obtained using two reference methods, i.e., visual analysis
of liver morphology by fluorescence microscopy and size analysis of fluorescent 2D liver images.
In addition, our study shows that administering compounds into the yolk is relevant in the framework
of hepatotoxicity testing. Taken together, cell imaging counting provides a novel and rapid tool
for screening hepatotoxicants in early stages of drug development. This method is also suitable
for testing of other organ-related toxicities subject to the organs and tissues expressing fluorescent
proteins in transgenic zebrafish lines.
Keywords: hepatotoxicity; drug-induced liver injury (DILI); zebrafish larvae; cell imaging
counting; pharmacokinetics
1. Introduction
Drug-induced liver injury (DILI) is the most common cause of liver injury affecting approximately
14–19 cases per 100,000 patient-years in Western patients. Among the patients diagnosed with DILI in
a French study, 6% died and 12% required hospitalization [1]. DILI is also the most common reason
for failures during the drug development process [2] and for safety-related withdrawal of drugs from
the pharmaceutical market [3]. Therefore, having tools and techniques that can detect hepatotoxic
properties in drug candidates at an early stage of discovery is highly desirable. Traditionally, this has
been accomplished by performing in vivo studies in mice and rats by measuring the serum alanine
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aminotransferase levels and by histological analysis of liver sections. However, these models are
time demanding, costly, and in addition interfere with the welfare of the animals. Hence there is an
urgent need to identify fast and cost-efficient methods using alternative models with high human
predictability that in the preclinical phase identify and exclude drugs with hepatotoxic properties.
Zebrafish (Danio rerio) are a promising small vertebrate animal model for use in biomedical
research and represent a powerful alternative model to implement the 3R principle of humane animal
research (replacement, reduction, and refinement) [4–6]. In the context of compound hepatotoxicity
testing the model offers several advantages. First and foremost, zebrafish show a high similarity
to mammals in hepatocyte metabolism and liver functionality [7] and display similar responses to
hepatotoxicants [4]. In addition, the zebrafish liver is fully functional at 72 hpf [5,8], so hepatic
responses after exposure of zebrafish larvae to hepatotoxicants can be monitored from an early stage
onwards. Secondly, zebrafish are highly amenable to medium/high throughput screening. One adult
pair of fish can produce approximately 200–300 eggs/week, resulting in access to large numbers of
eggs/embryos. Moreover, the developing zebrafish larvae have a size of 1–4 mm, thus experiments
can easily be performed in microtiter plates using only microgram amounts of compound.
Current hepatotoxicity testing using zebrafish includes endpoints such as liver degeneration
and yolk retention [6], expression of liver-specific fatty acid binding protein (lfabp10a) in hepatocytes,
and liver morphology using a Tg(fabp10a:DsRed) zebrafish transgenic line that specifically expresses
fluorescent DsRed in hepatocytes [9]. Unfortunately, all these methods require blinding of the
investigators to minimize bias and maximize the validity of the results. Besides, the 2D image-based
results do not necessarily reflect the actual 3D changes in the liver.
As hepatocytes account for 70%–75% of hepatic cells and carry out most of the liver functions [10],
it is anticipated that the reduction in number of hepatocytes after drug exposure is a key indicator
of hepatotoxicity. Presently, fluorescence-activated cell sorting (FACS) is the only method used to
estimate ex vivo the number of hepatocytes present in zebrafish [11]. However, as the procedure
requires single sample filtering and processing, the method is inherently slow and hence not suitable
for medium/high throughput purposes.
In this study cell imaging counting (CIC) was used to quantify the amount of DsRed-labeled
hepatocytes recovered from Tg(fabp10a:DsRed) transgenic zebrafish in a fast and straightforward way.
Two compounds known to cause hepatotoxicity in humans, i.e., paracetamol and tetracycline [6],
as well as two non-hepatotoxicants (sucrose and rutin) were selected for the study. The outcome was
compared with results found with commonly used hepatotoxicity-testing methods that are based on
assessing liver morphology.
The studies published to date only used immersion as the route of exposing zebrafish to
drugs investigating their hepatotoxic effects. This situation can result in false-negatives due to
poor absorption as observed when investigating cardiotoxicity [12]. We therefore also explored
the applicability of using yolk and pericardial injection as alternative administration routes for testing
hepatoxicants. Finally, we also studied the pharmacokinetics of paracetamol and tetracycline in
zebrafish larvae using the concerned administration routes.
2. Results
2.1. Determination of Maximum Non-Toxic Drug Concentration/Dose (MC/MD)
Using a range of concentrations/doses, we first determined the maximum non-toxic drug
concentration (MC, in case of immersion) or dose (MD, in case of injection), i.e., the highest
concentration/dose of compound causing insignificant larval death (less than 10%; see Figure 1) after
three days of treatment (immersion), or three days after treatment (injection), at 6 days post-fertilization
(dpf). In the case that an insignificant number of larval deaths were induced, the highest MC that
resulted in a clear solution (no precipitation) or MD that could be injected without precipitation
was used.
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Our results show that the two hepatotoxicants (paracetamol, tetracycline) caused larval death
in several of the conditions tested (Figure 1), whereas the non-hepatotoxicants (sucrose and rutin)
did not induce lethality even at the highest soluble concentration/dose (results not shown). Based
on these results, the MC/MD of each compound was determined. The MC or MD thus obtained, as
well as two serial dilutions (50%, 25%) were used as concentrations/doses (Tables 1–3) for further
hepatotoxicity testing.
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Figure 1. Lethality in Tg(fabp10a:DsRed) zebrafish larvae after immersion (a,b); yolk injection (c,d) 
and pericardial injection (e,f) of paracetamol (a,c,e) and tetracycline (b,d,f). Analysis was performed 
after three days of treatment (immersion) or three days after treatment (injection), at 6 days 
post-fertilization (dpf). A total of 10 and 12 larvae were used individually per condition for 
immersion and injections, respectively. The experiment was performed in triplicate and data were 
pooled. The results are expressed as percentage of dead larvae relative to the total larvae (mean ± 
SD). PAR: paracetamol; TET: tetracycline. 
  
Figure 1. Lethality in Tg(fabp10a:DsRed) zebrafish larvae after immersion (a,b); yolk injection (c,d) and
pericardial injection (e,f) of par cetamol (a,c,e and t tracycline (b,d,f). A alysis was performed after
three days of treatment (immersion) or three days after treatment (injection), at 6 days post-fertilization
(dpf). A total of 10 and 12 larvae were used individually per condition for immersion and injections,
respectively. The ex eriment was performed in triplicate and data were pooled. The results are
expressed as percentage of dead larvae relative to the total larvae (mean ± SD). PAR: paracetamol;
TET: tetracycline.
Table 1. Compound concentrations used for hepatotoxicity testing (immersion).
Compound Immersion Concentration (µM)
1/4 MC 1/2 MC MC
Paracetamol 1875 3750 7500
Tetracycline 250 500 1000
Sucrose 2000 4000 8000 1
Rutin 50 100 200 1
1 The highest soluble concentration. MC: maximum non-toxic drug concentration.
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Table 2. Compound doses used for hepatotoxicity testing (yolk injection).
Compound Injection Dose (mg/kg)
1/4 MD 1/2 MD MD
Paracetamol 151 302 604 1
Tetracycline 48 96 192
Sucrose 137 274 548 1
Rutin 38 75 150 1
1 The highest dose that can be injected without precipitation. MD: maximum non-toxic drug dose.
Table 3. Compound doses used for hepatotoxicity testing (pericardial injection).
Compound Injection Dose (mg/kg)
1/4 MD 1/2 MD MD
Paracetamol 151 302 604 1
Tetracycline 96 192 384 1
Sucrose 137 274 548 1
Rutin 38 75 150 1
1 The highest dose that can be injected without precipitation.
2.2. Hepatotoxicity Assessed by Visual Analysis of Liver Morphology Using Fluorescence Microscopy
First, we immersed or injected Tg(fabp10a:DsRed) zebrafish larvae with the hepatotoxicants at their
MC/MD (and dilutions) at 3 dpf and assessed their hepatotoxic effects after three days of treatment
(immersion) or three days after treatment (injection) by visual analysis of liver morphology using
fluorescence microscopy. We observed a range of abnormal liver phenotypes including reduced and
enlarged livers (Figure 2). Tetracycline induced abnormal liver morphology in a dose-dependent
manner in all three administration routes. Similar results were obtained with paracetamol, although
no significant toxic effects were observed after pericardial injections (Figure 3). The non-hepatotoxic
compounds (sucrose, rutin) did not induce abnormal liver morphology by any of the administration
routes (results not shown).
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Figure 2. Visual analysis of liver morphology using Tg(fabp10a:DsRed) zebrafish larvae by fluorescence 
microscopy (original 40× magnification). Larvae with normal liver morphology (a); and abnormal 
liver morphology (b–d). The liver area is identified as the yellow area. 
Figure 2. Visual analysis of liver morphology (fabp10a:DsRed) zebrafish larv e by fluorescence
mi roscopy (original 40× magnification). Larvae i r al liver morphology (a); nd abnormal
liver morphology (b–d). The liver area is identified as the yellow area.
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Figure 3. Hepatotoxicity assessed by visual analysis of liver morphology (by researchers blinded for 
the treatment conditions) using fluorescence microscopy after immersion (a,b); yolk injection (c,d) 
and pericardial injection (e,f) of paracetamol (a,c,e) and tetracycline (b,d,f). Analysis was performed 
after three days of treatment (immersion) or three days after treatment (injection), at 6 dpf. A total of 
10 and 12 larvae were used individually per condition for immersion and injections, respectively. 
The experiment was performed in triplicate and data were pooled. The results are expressed as the 
percentage of larvae having normal or abnormal liver morphology. The data were analyzed by 
Fisher’s exact test. ns: no statistically significant difference; *: p < 0.05; **: p < 0.01: ***: p < 0.001; VHC: 
vehicle control; PAR: paracetamol; TET: tetracycline. 
2.3. Hepatotoxicity Assessed by Size Analysis of Fluorescent 2D Liver Images  
Next, the 2D images obtained in the previous section were used to analyze the size of the 
fluorescent livers by ImageJ software. The results show that paracetamol and tetracycline were 
hepatotoxic only at their MC and not at lower concentrations. In case of injected hepatotoxicants, 
only paracetamol exhibited an effect at its MD after yolk administration (Figure 4). The non-hepatotoxic 
Figure 3. Hepatotoxicity assessed by visual analysis of liver morphology (by researchers blinded for
the treatment conditions) using fluorescence microscopy after immersion (a,b); yolk injection (c,d)
and pericardial injection (e,f) of paracetamol (a,c,e) and tetracycline (b,d,f). Analysis was performed
after three days of treatment (immersion) or three days after treatment (injection), at 6 dpf. A total
of 10 and 12 larvae were used individually per condition for immersion and injections, respectively.
The experiment was performed in triplicate and data were pooled. The results are expressed as the
percentage of larvae having normal or abnormal liver morphology. The data were analyzed by Fisher’s
exact test. ns: no statistically significant difference; *: p < 0.05; **: p < 0.01: ***: p < 0.001; VHC: vehicle
control; PAR: paracetamol; TET: tetracycline.
2.3. Hepatotoxicity Assessed by Size Analysis of Fluorescent 2D Liver Images
Next, the 2D images obtained in the previous section were used to analyze the size of the
fluorescent livers by ImageJ software. The results show that paracetamol and tetracycline were
hepatotoxic only at their MC and not at lower concentrations. In case of injected hepatotoxicants, only
paracetamol exhibited an effect at its MD after yolk administration (Figure 4). The non-hepatotoxic
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compounds (sucrose, rutin) did not induce any change in liver size as compared to livers of non-treated
animals by any of the administration routes (results not shown).
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Figure 4. Hepatotoxicity assessed by size analysis of fluorescent 2D liver images after immersion (a,b);
yolk injection (c,d) and pericardial injection (e,f) of paracetamol (a,c,e) and tetracycline (b,d,f). Analysis
was performed after three days of treatment (immersion) or three days after treatment (injection), at
6 dpf. A total of 10 and 12 larvae were used individually per condition for immersion and injections,
respectively. The experiment was performed in triplicate and data were pooled. The data were analyzed
using one-way ANOVA. ns: no statistically significant difference; *: p < 0.05, ***: p < 0.001; VHC: vehicle
control; PAR: paracetamol; TET: tetracycline. Means ± SD are shown.
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2.4. Quantification of Recovered Hepatocytes by Cell Imaging Counting (CIC)
In order to use CIC for ex vivo quantification of the number of hepatocytes, we used a transgenic
line Tg(fabp10a:DsRed) expressing DsRed in hepatocytes under the fabp10a promoter. To dissociate
and recover hepatocytes from the larvae we investigated the effect of different common proteases
(trypsin, collagenase and dispase) and mechanical forces (shaking, pipetting, and needle/syringe).
We found that dispase, in combination with a gentle up and down pipetting of the digested
larvae, resulted in a high recovery of well-separated and viable hepatocytes (Figure 5), whereas
the other enzymes were not effective (collagenase) or highly toxic (trypsin) to the dissociated cells
(results not shown).
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Figure 5. DsRed-labeled hepatocytes captured by cell imaging counting (CIC). Yellow dots represent
single hepatocytes.
To d monstrate the reproducibility of the method we quantified epatocytes isolated from 6 dpf
larvae (n = 80) incubated between 3 and 6 dpf with 1% dim thyl sulfoxide (DMSO) (v hicle control).
Th procedure was independ ntly repeated three times, and the data wer pooled. The a erage
number of hepatocytes recovered amounted to 1509 ± 328 (average ± standard deviation (SD)) per
larva (n = 240).
2.5. Hepatotoxicity Assessed by Quantification of DsRed-Labeled Hepatocytes Using Cell Imaging
Counting (CIC)
We then used CIC and quantified ex vivo DsRed-labeled hepatocytes after dispase-digestion
of hepatotoxicant-exposed larvae. The results show that this approach detected hepatotoxic effects
induced by all three tetracycline concentrations. In case of paracetamol, only the MC triggered
hepatotoxicity. As far as the injected doses are concerned, tetracycline showed no effects, whereas
paracetamol was hepatotoxic in case of yolk administration (two concentrations) but also in case of the
pericardial injection (only at MD) (Figure 6).
The non-hepatotoxic compounds (sucrose, rutin) did not induce any change in the amount of
recovered hepatocytes as compared to the amount coming from livers of non-treated animals by any
of the administration routes (results not shown).
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tetracycline (b,d,f). Analysis was performed after three days of treatment (immersion) or three days 
after treatment (injection), at 6 dpf. A total of 10 and 12 larvae were used individually per condition 
for immersion and injections, respectively. The experiment was performed in triplicate and data 
were pooled. The data were analyzed using one-way ANOVA. ns: no statistically significant 
difference; *: p < 0.05; ***: p < 0.001; VHC: vehicle control; PAR: paracetamol; TET: tetracycline. Means 
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2.6. Pharmacokinetics of Hepatotoxicants in Zebrafish Larvae 
In order to investigate the pharmacokinetics of paracetamol and tetracycline after immersion or 
injection at their MC/MT, we quantified the compounds in larval extracts as a function of time (0–24 
h post treatment) using ultra-high performance liquid chromatography with ultraviolet detection 
(UHPLC-UV). The validation data of the extraction and chromatography method can be found in the 
Appendix. The results show that in the case of immersion, the uptake of the compounds increased 
gradually as a function of time (Figure 7). Compared to tetracycline, paracetamol reached higher 
Figure 6. Hepatotoxicity assessed by quantification of DsRed-labeled hepatocytes using a CIC after
immersion (a,b); yolk injection (c,d) and pericardial injection (e,f) of paracetamol (a,c,e) and tetracycline
(b,d,f). Analysis was performed after three days of treatment (immersion) or three days after treatment
(injection), at 6 dpf. A total of 10 and 12 larvae were used individually per condition for immersion and
injections, respectively. The experiment was performed in triplicate and data were pooled. The data
were analyzed using one-way ANOVA. ns: no statistically significant difference; *: p < 0.05; ***: p < 0.001;
VHC: vehicle control; PAR: paracetamol; TET: tetracycline. Means ± SD of the number of hepatocytes
per larva are shown.
2.6. Pharmacokinetics of Hepatotoxicants in Zebrafish Larvae
In order to investigate the pharmacokinetics of paracetamol and tetracycline after immersion
or injection at their MC/MT, we quantified the compounds in larval extracts as a function of time
(0–24 h post treatment) using ultra-high performance liquid chromatography with ultraviolet detection
(UHPLC-UV). The validation data of the extraction and chromatography method can be found in the
Int. J. Mol. Sci. 2017, 18, 356 9 of 17
Appendix A. The results show that in the case of immersion, the uptake of the compounds increased
gradually as a function of time (Figure 7). Compared to tetracycline, paracetamol reached higher larval
concentrations after 24 h, in line with the higher immersion concentrations used (1000 and 7500 µM,
respectively). After both the yolk and pericardial injections (604 mg/kg), larval concentrations of
paracetamol decreased over time with a half-life of 6–8 h. The compound was fully excreted or
metabolized after 24 h. In contrast, larval tetracycline remained nearly constant in the 0–24 h period
after injection. The amounts recovered after pericardial injections were about the double as compared
to the quantity found after yolk injections. This is in agreement with the amount of tetracycline injected,
i.e., 384 and 192 mg/kg, respectively).
Int. J. Mol. Sci. 2017, 18, 356 9 of 17 
 
larv l concen rations after 24 h, in lin  wit  the higher immersion conce trations used (1000 and 
7500 µM, respectively). After both the yolk and pericardial injections (604 mg/kg), larval 
concentrations of paracetamol decreased over time with a half-life of 6–8 h. The compound was fully 
excreted or metabolized after 24 h. In contrast, larval tetracycline remained nearly constant in the 0–
24 h period after injection. The amounts recovered after pericardial injections were about the double 
as compared to the quantity found after yolk injections. This is in agreement with the amount of 
tetracycline injected, i.e., 384 and 192 mg/kg, respectively). 
 
(a)
 
(b)
Figure 7. Pharmacokinetics after immersion, yolk and pericardial injection of paracetamol (a) and 
tetracycline (b). The compounds in larval extracts were quantified by ultra-high performance liquid 
chromatography with ultraviolet detection (UHPLC-UV) as a function of time (0–24 h post 
treatment). n = 3, *: consists of two measurements. Means ± SD are shown. 
3. Discussion 
The first objective of this study was to evaluate cell imaging counting (CIC) as a new and 
efficient approach for ex vivo hepatotoxicity assessment in zebrafish larvae. CIC is a high-content 
imaging and quantification tool that is used for detecting cells and even changes in cells at a 
subcellular level [13,14]. Using a transgenic zebrafish line that specifically expresses fluorescent 
DsRed in the hepatocytes, we were able to quantify the amount of recovered hepatocytes in a 
reproducible way, even after a simple protease-digestion of the larvae in combination with a short 
centrifugation step. Indeed, in contrast to FACS analysis of cells recovered from whole organisms 
that needs sample filtering in order to prevent lines from clogging [11], our CIC-based method 
allows the straightforward detection of a limited number of fluorescent cells in the midst of 
non-fluorescent debris, without the need for time-consuming purification steps. This implies that the 
method can be used to test larger collections of compounds in a medium-throughput way.  
Figure 7. Pharmacokinetics after immersion, yolk and pericardial injection of paracetamol (a) and
tetracycline (b). The compounds in larval extracts were quantified by ultra-high performance liquid
chromatography with ultraviolet detection (UHPLC-UV) as a function of time (0–24 h post treatment).
n = 3, *: consists of two measurements. Means ± SD are shown.
3. Discussion
The first objective of this study was to evaluate cell imaging counting (CIC) as a new and efficient
approach for ex vivo hepatotoxicity assessment in zebrafish larvae. CIC is a high-content imaging and
quantification tool that is used for detecting cells and even changes in cells at a subcellular level [13,14].
Using a transgenic zebrafish line that specifically expresses fluorescent DsRed in the hepatocytes,
we were able to quantify the amount of recovered hepatocytes in a reproducible way, even after a
simple protease-digestion of the larvae in combination with a short centrifugation step. Indeed, in
contr st to FACS analysis of cells recovered from whole organisms that n eds sample filtering in order
to prevent lin from clogging [11], our CIC-based method allows he raightforward detection of
a limit d number of flu r cent cells in the midst of non-fluorescent debris, without the need for
time-consuming purification steps. This implies that the method can be used to test larger collections
of compounds in a medium-throughput way.
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To evaluate the sensitivity of CIC to detect drug-induced hepatotoxicity, visual analysis of
liver morphology by fluorescence microscopy and size analysis of fluorescent 2D liver images were
employed as reference methods. The data show that all three methods were able to identify the
hepatotoxic effects of paracetamol and tetracycline, at least when larvae were immersed in the
non-lethal maximal concentration (MC) (Table 4). As compared to the other methods, CIC was
more sensitive in detecting the effects induced by tetracycline at concentrations lower than MC. CIC
also identified hepatotoxicity induced by paracetamol at MD via both yolk injection and pericardial
injection, whereas the other methods were only successful for yolk injections. However, liver
morphology assessment turned out to be more sensitive than CIC, e.g., in case of pericardial or
yolk injections of tetracycline (Table 4). In general, this study also suggests that by combining visual
assessment of liver morphology and CIC, a proper strategy is obtained for a very successful screening
of the hepatotoxicity of compounds. As a matter of fact, by combining these methods, both paracetamol
and tetracycline are recognized as hepatotoxic compounds via any of the three administration routes.
Table 4. Detection of compound-induced hepatotoxicity by the three methods.
Method
Treatment
Immersion Yolk Injection Pericardial Injection
1/4 MC 1/2 MC MC 1/4 MD 1/2 MD MD 1/4 MD 1/2 MD MD
Paracetamol
Morphology 1 NS S S NS S S NS NS NS
Liver size 2 NS NS S NS NS S NS NS NS
# Hepatocytes 3 NS NS S NS S S NS NS S
Tetracycline
Morphology 1 NS NS S NS NS S NS S S
Liver size 2 NS NS S NS NS NS NS NS NS
# Hepatocytes 3 S S S NS NS NS NS NS NS
1 Visual analysis of liver morphology by fluorescence microscopy; 2 Size analysis of fluorescent 2D liver images;
3 Analysis of amount of DsRed-labeled hepatocytes by CIC; # number of; Bold S: statistically significant difference;
NS: no statistically significant difference.
The reason underlying the differences in sensitivity of the three methodological approaches is
presently not clear. Obviously, further studies including detailed microscopic analyses of liver sections
are needed that would allow us to correlate the outcome, as observed in this study, with histological
changes and cellular viability.
Herein we also explored the applicability of using injections for the delivery of compounds
investigated for their hepatotoxic effects. In case of paracetamol a clear effect was detected after yolk
injection at MD, as identified by all three methods. Thus hepatotoxicity can also be induced by a
single overdose of paracetamol in zebrafish larvae, as observed for humans [15]. Tetracycline induced
pronounced effects, both after yolk and pericardial injections, although the hepatotoxicity was detected
only by visual analysis of liver morphology, and not by the other methods (Table 4).
Overall, the outcome therefore shows that also injections, especially in case of administering
compounds into the yolk, can produce significant results in the framework of hepatotoxicity testing.
However, as the pharmacokinetic data indicate that both paracetamol and tetracycline are absorbed by
immersion, leading to obvious liver effects, it is not clear from the present data that yolk injections
could be advantageous over simple bathing of larvae in compound solutions. Obviously, the yolk
administration route that can also be performed automatically [16] is particularly of interest when
testing hepatotoxicity of compounds that are poorly absorbed, i.e., in case of highly hydrophilic or
large compounds [12].
The pharmacokinetic profile of paracetamol shows that almost no compound could be recovered
from the larvae 24 h after yolk injection, although the hepatotoxic effects detected at 6 dpf are similar
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to the immersion results. This seems to indicate that the injurious effects take place particularly
during the first 24 h after administration (3–4 dpf). Alternatively, it is possible that metabolites like
N-acetyl-p-benzoquinone imine (NAPQI) are formed (not tracked down in this study) that exert their
effect over time. Of interest, NAPQI-GSH adduct (GSH is the reduced form of glutathion) has been
found when paracetamol was incubated with liver microsomes of adult zebrafish, possibly as the
result of the expression of cytochromes P450 (CYPs), CYP3A65 with contributions of CYP3C1 [17].
Of interest, the genes for these CYPs are expressed in embryonal zebrafish as well [18], although it is
not known whether the protein concentrations reach functional levels.
Interestingly, the pharmacokinetic profiles after yolk or pericardial injection of paracetamol are
somewhat similar, although the hepatotoxic effects induced were different. Likely, both administration
routes result in a dissimilar overall distribution of the compound in organs and tissue, affecting the
final hepatotoxic effect.
In case of injected tetracycline, different pharmacokinetic profiles were observed as compared
to the ones seen after injection of paracetamol. The concentrations remained somewhat constant
over the first 24 h after administration, and it looks like the compound is not readily excreted from
the larval body. It is possible that tetracycline binds to a large extent and with high affinity to
local tissue without being distributed over the rest of the larvae. Anyhow, the final hepatotoxicity
induced by the different administration routes as detected by liver morphology analysis is surprisingly
quite similar. In contrast, when using CIC to assess hepatotoxicity, immersion led to pronounced
effects (all concentrations active), whereas no impact was observed after injection. Again, the overall
outcome regarding tetracycline is likely the consequence of a complex interplay between distribution,
metabolism and detection of hepatotoxicity. These first intriguing results regarding pharmacokinetics
and organ toxicity in zebrafish larvae definitely demand further investigation, and it looks like detailed
metabolism data are required to fully understand the results. However, this experimental work was
beyond the scope of the present study.
4. Materials and Methods
4.1. Chemicals
Paracetamol, tetracycline, sucrose and rutin were purchased from Sigma-Aldrich (St. Louis,
MO, USA).
Protease inhibitor cocktail (1.5× solution) was made by dissolving 1 tablet (cOmplete mini
Protease Inhibitor Cocktail Tablets, Roche, Basel, Switzerland) in 6.5 mL Dulbecco’s phosphate-buffered
saline (DPBS) (Life Technologies, Ledeberg, Belgium) without calcium and magnesium.
Dispase II (Sigma-Aldrich) was dissolved in DPBS (Life Technologies, Ledeberg, Belgium) without
calcium and magnesium to make a 20 mg/mL stock solution.
UHPLC experiments were performed using ammonium formate purchased from Fluka
(Buchs, Switzerland). Formic acid was obtained from Acros Organics (Geel, Belgium), acetonitrile and
methanol was purchased from Fischer Scientific (Loughborough, UK). All reagents were of analytical
grade or better. Ultrapure water was produced using a Millipore Milli-Q Gradient system (Milford, MA,
USA). All pH modifications were done with a Metrohm 691 pH meter (Antwerp, Belgium).
4.2. Zebrafish
All zebrafish experiments carried out were approved by the Ethics Committee of the University
of Leuven (approval number P154/2015, the start date: 1 October 2015, the end date: 30 September
2019) and by the Belgian Federal Department of Public Health, Food Safety & Environment
(approval number LA1210261).
A transgenic zebrafish line expressing DsRed in hepatocytes under the fabp10a promoter
(herein referred to as Tg(fabp10a:DsRed)) was created and raised in our laboratory [9]. Tg(fabp10a:DsRed)
zebrafish (larvae and adults) were kept in standard conditions for zebrafish (28 ◦C, 14/10-h light/dark
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cycle). Tg(fabp10a:DsRed) adults from the third and fourth generation were mated (two males and
three females per cage). Only embryos of good quality (fertilized, clear cytoplasm and symmetric
cleavage) were selected for experiments and kept in petri dishes containing Danieau’s solution until
compound exposure. All larvae were derived from the same spawns of eggs for statistical comparison
between the control and treated groups.
4.3. Compound Administration
Compounds tested were dissolved in DMSO (stock solution) and then further diluted in Danieau’s
solution with a final concentration of 1% DMSO or diluted with 0.9% NaCl solution (1:1 ratio) to obtain
a working solution for immersion and yolk/pericardial injections, respectively. At 3 dpf, hatched
Tg(fabp10a:DsRed) larvae were transferred to 24-well plates (Falcon®, Corning, Lasne, Belgium) with
each well containing 10 larvae in 1 mL Danieau’s solution and the dissolved drug or the vehicle control
for immersion. For yolk injections, and pericardial injections into the bloodstream via the common
cardinal veins [19,20], 12 larvae were used for each condition, and each larva was injected with 1 nL of
solution at 3 dpf.
4.4. Hepatotoxicity Assessed by Visual Analysis of Liver Morphology Using Fluorescence Microscopy and Size
Analysis of Fluorescent 2D Liver Images
At 6 dpf treated larvae were anesthetized by 0.5 mM tricaine in a 6 well-plate (Falcon®) and
arranged so that they were lying on their right sides with their heads facing left. This enabled us to view
the left lateral side of the larvae and the larger lobe of the liver that was scored in a blinded manner
under a fluorescence microscope (Leica MZ10F-Dsred channel, 40×magnification, Leica Microsystems,
Wetzlar, Germany). Livers were considered abnormal if their typical globular structure underwent
gross morphological changes. Images of the livers (including a scale bar) were imported to ImageJ
software (National Institutes of Health, Bethesda, MD, USA) for determining the liver size. To that
end, the picture was set to scale (functions: analyze, set scale), the liver area extracted (functions: split
channel, threshold) and the area calculated (function: analyze particles, settings: size = 0−infinity,
circularity = 0.00−1.00).
4.5. Quantification of Hepatocytes Using Cell Imaging Counting (CIC)
4.5.1. Larvae Digestion and Recovery of Hepatocytes
In order to digest the larvae and separate hepatocytes from the liver, larvae were transferred
to 96 well-plates (Falcon®, Corning, Lasne, Belgium) with one larva per well and incubated with
200 µL 2.5 mg dispase/mL DPBS for 4 h. The proteolytic activity was stopped by adding 100 µL of
1.5× protease inhibitors cocktail solution. The hepatocytes were dispersed by pipetting up and down
20 times with a 1 mL automatic pipette. After digestion, hepatocytes were positioned at the bottom
of the well by centrifugation at 200× g (Jouan CR412 centrifuge, Jouan, Saint-Herblain, France) for
15 min.
4.5.2. Cell Imaging Counting (CIC) of Hepatocytes
Fluorescent hepatocytes present in the wells were imaged and counted on an IN Cell Analyzer
2000 using software IN Cell Investigator Developer Toolbox (GE Healthcare, Machelen, Belgium), with
a 2×/0.1 NA lens, DsRed fluorescence channel, a 0.1-s exposure time, and the intensity segmentation
(172-4095) set to ensure hepatocytes were recognized selectively.
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4.6. Pharmacokinetics Study of Hepatotoxicants
4.6.1. Sample Preparation
At given time points (0, 2, 6, 12 and 24 h), treated larvae were collected and transferred to 1.5 mL
Eppendorf® tubes pre-filled with acid washed glass beads (diameter: 710–1180 µm, Sigma-Aldrich)
and 270 µL of extraction medium (1:2 water:methanol, each containing 0.1% formic acid) was added
(10 larvae per Eppendorf® tube). Samples were centrifuged for 15 s at 14,100× g (Eppendorf Mini Spin
Plus, Hamburg, Germany) to insure high homogenization efficiency. Subsequently, the samples were
homogenized with ultrasonication (Diagenode Bioruptor Plus, Seraing, Belgium) at +4 ◦C and high
energy input setting to ensure the highest possible disruption of the cells. The overall treatment time
was 15 min spread over 30 cycles of 30 s treatment followed by pauses of 30 s in-between. Six samples
were homogenized during each treatment cycle. Subsequently, treated samples were centrifuged
at 14,100× g for 15 min and 200 µL of supernatant was transferred to an empty Eppendorf tube
(1.5 mL) and stored on ice until all samples were processed. All samples were then placed into a
vacuum oven (Model 1410, Sheldon Manufacturing Inc., Cornelius, OR, USA) and evaporated until
dry at +45 ◦C during 45 min. The samples were then reconstituted with a mobile phase-like solution
(6% acetonitrile in water), vortexed for 5 s, resuspended at least three times with a micropipette and
sonicated (Branson 3510, Danbury, CT, USA) for 15 min. The reconstitution volume was chosen such
that the linearity range of the method was not exceeded and is given in Table 5. Finally, samples were
transferred into amber glass vials (Supelco, Bellefonte, PA, USA) with 250 µL glass inserts (Supelco)
for further analysis on UHPLC-UV.
Table 5. Reconstitution volumes for different administration routes.
Administration Route
Reconstitution Volume (µL)
Paracetamol Tetracycline
Immersion 50 50
Yolk injection 100 50
Pericardial injection 100 50
4.6.2. Instrumental Analysis
An Agilent 1290 UHPLC system (Agilent, Waldbronn, Germany) consisting of an autosampler,
quaternary pump, degasser and DAD-detector (diode array detector) was used for all uptake
measurements. Data acquisition and peak processing was performed using OpenLAB CDS
Chemstation Edition 01.04 software (Agilent). All calculations concerning the evaluation of recorded
data were made in MS Excel (Microsoft Corporation, Seattle, WA, USA).
Compounds of interest were separated chromatographically on an Acquity BEH C18 column
(100 mm × 2.1 mm, dp (particle diameter) = 1.7 µm) from Waters Inc. (Milford, MA, USA) at a flow
rate of 0.4 mL/min. Gradient elution was performed starting at 97:3 (v/v) 10 mM ammonium formate
(pH 2.8 modified with formic acid):acetonitrile, and changed to 18:82 (v/v) 10 mM ammonium formate
(pH 2.8):acetonitrile in 10.5 min. The injection volume (Vinj) of each sample was 2 µL. After elution of
the compounds, a cleaning step at 100% acetonitrile was applied for 1.3 min after which the column
was re-equilibrated for 7.0 min at initial conditions. Paracetamol was detected at a wavelength of
254 nm, while a wavelength of 274 nm was used for the measurement of tetracycline.
The larval amount of hepatotoxicant (mg/kg) was calculated assuming the weight of a 3 or 4 dpf
Tg(fabp10a:DsRed) zebrafish larva to be 0.25 mg.
4.7. Statistical Analysis
Differences between drug-treated groups and control vehicle control (VHC) regarding numbers
of hepatocytes and liver sizes were analyzed for statistical significance using an ANOVA test.
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Regarding the liver morphology, Fisher’s exact test was used for the analysis. p < 0.05 was considered
statistically significant.
5. Conclusions
We successfully applied CIC ex vivo to detect hepatotoxicity induced by paracetamol and
tetracycline in our transgenic zebrafish model. The outcome was in general comparable with the
results obtained using two reference methods, i.e., visual analysis of liver morphology by fluorescence
microscopy and size analysis of fluorescent 2D liver images, although clear differences exist depending
on the administration routes investigated, i.e., immersion, yolk and pericardial injections. In general,
immersion of larvae resulted in more consistent results among the different hepatotoxicity tests.
Unlike the other methods, our CIC-dependent approach measures directly and in an unbiased
way the effect of compounds on the number of hepatocytes in the liver, is quick and reliable, and
therefore provides a novel and straightforward tool for screening hepatotoxicants in early stages of
drug development. As CIC allows for high-content imaging, the system is also amenable to more
detailed analysis of recovered cells, e.g., multiparametric cytotoxicity testing. In addition, the method
is also suitable for testing of other organ-related toxicities subject to the organs and tissue expressing
fluorescent proteins in transgenic zebrafish lines.
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Abbreviations
CIC Cell imaging counting
Dpf Days post-fertilization
HLQ Highest limit of quantification
Hpf Hours post-fertilization
Lfbp Liver fatty acid binding protein
LOQ Lowest limit of quantification
MC Maximum non-toxic drug concentration
MD Maximum non-toxic drug dose
MQC Medium quantified concentration
RSD Relative standard deviation
UHPLC Ultra-high performance liquid chromatography
UV Ultraviolet
VHC Vehicle control
Appendix A. Method Validation of Compound Quantification
Appendix A.1. Method Recovery
To determine method recovery, a first set of evaporated samples was prepared drug-free and
then spiked with 10 µg/mL of each compound dissolved in DMSO (as depicted in Section 4.3)
during the reconstitution step (Vreconstitution = 200 µL). Those samples showed the response Ax1 (area of
compound), which was unaffected by the sample preparation, though still reflecting possible influences
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of matrix on the chromatographic separation. A second set of samples contained extraction medium
spiked with the same concentration as in Ax1 and underwent the described preparation procedure
with an equal reconstitution volume of 200 µL. In this way, the obtained response Ax2 was connected
to the compound loss during sample preparation. Method recovery was then calculated as follows:
Recovery [%] = 100% × Ax2
Ax1
(A1)
The obtained recovery values of 140.4% for paracetamol and 107.2% for tetracycline (Table A1)
were considered to be satisfactory by taking into account low relative standard deviation (RSD) values
of 1.2% and 0.1% accordingly and thus high repeatability of the data.
Table A1. Recoveries of paracetamol and tetracycline in zebrafish larvae 4 days post-fertilization (dpf).
Compound Recovery (%) RSD (%)
Paracetamol 140.4 1.2
Tetracycline 107.2 0.1
Appendix A.2. Ultra-High Performance Liquid Chromatography-Ultraviolet ((UHPLC-UV) Method Validation
The developed instrumental method was validated with respect to linearity, limit of quantification,
matrix effects and carry-over. Precision was tested at three concentration points: lowest limit of
quantification (LOQ), medium quantified concentration (MQC) and highest limit of quantification
(HLQ), while repeatability was determined for two concentration points: LOQ and HLQ. Each
concentration was injected three times (precision) or six times (repeatability) to obtain RSD values,
respectively. RSD limits were set to 20% near LOQ and 15% at other concentration points following
the latest guidelines for method validation [21].
Appendix A.3. Linearity, LOQ
The determination of linearity was performed in standard solutions of 6% acetonitrile in water
containing compounds of interest at least 8 calibration points, while the obtained peak areas were
plotted versus known concentrations. Paracetamol was tested at 0.02, 0.16, 0.33, 0.75, 1.5, 3, 6, 12,
and 24 µg/mL and tetracycline at 0.25, 0.5, 1, 2, 4, 8, 16, and 32 µg/mL to define a curve range
complying to linear model with R2 ≥ 0.995. The lower limit of quantification (LOQ) was defined as
the concentration point where the signal of the analyte was 10 times higher than the noise.
Linearity curves were recorded for paracetamol and tetracycline in standard solutions.
The R2 value was 0.9998 or better for paracetamol in the range 0.02–24 µg/mL and for tetracycline
in the range 0.25–32 µg/mL (Table A2), while starting concentration was chosen corresponding to
LOQ. These LOQ values were found to be similar to others determined in earlier studies involving
UHPLC-UV equipment [22].
Table A2. Linearity of paracetamol and tetracycline; observed matrix effects. LOQ: lower limit
of quantification.
Compound Linearity Range (µg/mL) LOQ (µg/mL) R2 Matrix Effect (%)
Paracetamol 0.02–24 0.02 1 101
Tetracycline 0.25–32 0.3 0.9998 102
Appendix A.4. Precision and Repeatability
Intermediate precision was determined for three different concentrations (0.025, 12, and 24 µg/mL
for paracetamol and 0.25, 12.8, and 32 µg/mL for tetracycline) prepared and analyzed on three different
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days for both compounds. Simultaneously to those measurements a repeatability study was performed,
requiring three additional injections (n = 6) at LOQ and HLQ.
Method precision was investigated by executing three injections at three different concentration
levels (LOQ, MQC, HLQ) on three different days in standard solutions. Experiments revealed the
highest RSD values at 8.1% (Table A3), thus in line with the limits (RSD < 15%) mentioned before and
showing good precision of the obtained method for paracetamol and tetracycline.
Two samples in standard solutions of both compounds prepared at different concentrations
(LOQ, HLQ) were analyzed six times each to determine method repeatability. The highest RSD value
of 4.5% was obtained for LOQ of paracetamol displaying good overall reproducibility of the method.
Table A3. Determined repeatability and intermediate precision values for paracetamol and tetracycline.
HLQ: highest limit of quantification; MQC: medium quantified concentration.
Compound Repeatability Precision
LOQ (%) HLQ (%) LOQ (%) MQC (%) HLQ (%)
Paracetamol 4.5 0.3 4.6 0.4 0.4
Tetracycline 3.3 0.5 3.4 8.1 7.7
Appendix A.5. Matrix Effects and Carry-Over
Matrix effects were investigated by spiking evaporated blank samples of 4-dpf larvae (n = 10)
with concentrations of 1.5, 6, and 24 µg/mL for paracetamol and concentrations of 2, 8, and 32 µg/mL
for tetracycline and comparing the slope of the obtained linearity curve to those in standard solutions.
The same matrix behavior was assumed for 3-dpf and 6-dpf larvae. Carry-over was examined
by injecting drug-free standards or zebrafish solutions after each concentration level during the
linearity measurements.
No significant deviations between measured concentrations in standard solutions and spiked
zebrafish samples could be detected (Table A2), allowing for validation of the developed method in
standard solutions. Following these results, the same matrix behavior was assumed for 3 and 6-dpf
zebrafish larvae. Carry-over examination in the drug-free standards or zebrafish solutions revealed no
carry-over records for either compound at any concentration levels.
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